FAKTOR-OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 15:39:27 2024-05-10 EDT | ||
| 2.13 EUR | +0.95% |
|
| Current month | +9.23% | ||
| 1 month | +30.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 2.13 | +0.95% | 0 |
| 24-05-09 | 2.11 | +1.44% | 0 |
| 24-05-08 | 2.08 | +2.97% | 0 |
| 24-05-07 | 2.02 | -2.88% | 0 |
| 24-05-06 | 2.08 | +4.52% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 10, 2024 at 03:39 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SF57U3 |
| ISIN | DE000SF57U35 |
| Date issued | 2021-11-01 |
| Strike | 264.9 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 9.97 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.84 € |
|---|---|
| Lowest since issue | 1.34 € |
| Spread | 0.01 € |
| Spread % | 0.47% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
221.5
USD
Average target price
285.9
USD
Spread / Average Target
+29.08%
- Stock Market
- Certificates
- Certificat
